Central Laboratories Featured Articles

  1. Multiple Partnerships Help Drive Precision Medicine Trial For Parkinson's 3/31/2025

    Neuron23 CMO Sam Jackson, MD, explains the company’s desire to set a new standard in precision medicine for neurology, backed by well-aligned partnerships and fit-for-purpose digital biomarker solutions. 

  2. If Patients Want A Better Quality Of Life, Why Isn't That A Focus For Pharma? 3/25/2025

    Medical oncologist Frédéric Fiteni, Ph.D. reveals the widespread industry reluctance to study patient quality of life, describes its importance to patient satisfaction, and offers best practices for its integration.

  3. A Decade Of Data Sharing: Insights From J&J And Yale's YODA Project 3/12/2025

    Joseph S. Ross, MD, MHS, and Karla Childers, MS reflect on a decade of data sharing and the lasting impact of the Yale University Open Data Access (YODA) Project on clinical research. 

  4. Tired Of Manually Reviewing Disparate Data? Try Integrated Data Review 3/11/2025

    Integrated Data Review (IDR) has emerged to offer a unified, real-time approach to managing clinical trial data by consolidating diverse datasets on a single platform. 

  5. Is Double Programming Really Required For Validation? 3/10/2025

    Double programming has been the gold standard for validation, but technological advancements and improved sponsor oversight of CRO deliverables have introduced more efficient and reliable alternatives.

  6. Breaking Down The FDA's Latest Guidance On Electronic Systems In Clinical Investigations 2/28/2025

    In October, the FDA took a significant step forward by releasing a new Q&A guidance clarifying the use of electronic systems, e-records, and e-signatures in clinical investigations.

  7. Are We On The Cusp Of A Quantum Revolution In Clinical Trials? 2/28/2025

    Though quantum computing is still in a nascent stage, life sciences companies are already investing in this technology to enhance predictive models, improve site selection, and find the right cohort.

  8. Tackling AI Copyright Challenges In Pharma And Clinical Research 2/21/2025

    Pistoia Alliance President Becky Upton, Ph.D. explains pharma and clinical research organizations must collaborate to address copyright and data-sharing challenges with or AI — or risk stalling innovation.

  9. What ClinOps Wants To Know About AI 2/13/2025

    Registrants for our recent Clinical Leader Live, “AI In Action: Transforming Clinical Trials,” were asked what they wanted to learn after watching the webinar. We thought it would be interesting to look at the five general themes to the types of questions they were asking.

  10. A Tool To Tackle The Risk Of Uninformative Trials 1/31/2025

    Uninformative trials hinder progress in clinical practice, policy decisions, and further research. Fast Data Science developed a free risk tool to help pharma companies avoid them.